Bradley Wiggins’ performance in Tour de France win ‘enhanced’: investigation

UPDATED ON MAR 05, 2018 07:06 PM IST
About The Video

Sir Bradley Wiggins used a banned powerful corticosteroid to enhance his performance while preparing to win the Tour de France in 2012, a British parliamentary committee said in a doping investigation report which accuses Team Sky of crossing an “ethical line” after preaching zero tolerance. The legislators said they received evidence which shows Team Sky sought a therapeutic use exemption (TUE) for Wiggins to take triamcinolone “not to treat medical need” - asthma - “but to improve his power to weight ratio.” “We believe this powerful corticosteroid was being used to prepare Bradley Wiggins, and possibly other riders supporting him, for the (2012) Tour de France,” the House of Commons select committee said in the report published Monday. “He benefited from the performance-enhancing properties of this drug during the race.” In a statement, Wiggins denied “any drug was used without medical need.” (Video courtesy – SNTV)


Story Saved